New Assay Expands Application Range of Agilent Seahorse XF Technology SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced the Agilent Seahorse XF Real-Time ATP Rate Assay Kit, a new product that will enable biologists to enhance their understanding of how live-cells function in real-time. The Seahorse XF Real-Time ATP Rate Assay Kit enables […]
Daiichi Sankyo and Takeda Pharmaceuticals to leverage FDA-approved test for clinical trials and drug development programs CARLSBAD, Calif. — Thermo Fisher Scientific announced today it has signed new agreements with Daiichi Sankyo and Takeda Pharmaceuticals designed to expand the clinical utility of Oncomine Dx Target Test in support of clinical trials and drug development programs at each of the firms. […]
LGC has today announced a further strengthening of its nucleic acid chemistry (NAC) offering with the acquisition of BioAutomation Corporation (BioAutomation), manufacturer of the renowned MerMade oligo synthesis instruments. This investment follows LGC’s acquisitions of Biosearch, Prime Synthesis and LINK Technologies, and will drive further growth in the oligonucleotide reagent and synthesised oligonucleotides markets. Brian Kim, President and Managing […]
Eagle Genomics has appointed Executive Chairman Anthony Finbow to the post of Chief Executive, with founder Abel Ureta-Vidal moving to become Chief Product Officer. The change in management structure marks a new phase for Eagle Genomics as the organisation rapidly shapes for scale to meet customer demand. The company has won 11 enterprise customers since its […]
Multi-Electrode Array (MEA) Offers New Route for Type 2 Diabetes Drug Development and Ability to Elucidate Beta Cell PathophysiologyHOLLISTON, Mass.2 — Multi Channel Systems (MCS), a subsidiary of Harvard Bioscience, Inc., launched its Beta Cell-System, a new, non-invasive beta cell screening system for diabetes research. The Beta Cell-System leverages MCS’s multi electrode array (MEA) technology to […]
See Change with the new AQS3pro System for protein characterization from RedShiftBio. One highly automated system, five key measurements: Aggregation, Quantification, Stability, Structure and Similarity Boston, MA At PEGS 2018 (April 30th – May 4th, Boston, MA) RedShift™ BioAnalytics, Inc. (RedShiftBio™) will unveil the AQS3™pro, a new protein characterization platform with powerful, integrated bioanalytics software […]
Laboratory network standardizes on common NGS platform to efficiently profile patient samples across multiple cancer centers CARLSBAD, Calif. — At risk cancer patients across Canada may now be able to have their tumors molecularly profiled using next-generation sequencing (NGS) as part of a national effort to expedite enrollments in clinical trials. Led by Exactis Innovation, a non-profit organization […]
Lincoln, Nebraska: LI-COR Biosciences is pleased to announce that Bargal Analytical Instruments is appointed to distribute LI-COR Biotechnology Products in Israel effective May 1, 2018. “Bargal is well known for its dedication to excellent service and support. They share LI-COR’s commitment to helping customers find the right solutions to each unique research challenge,” says Alisa Murray, […]
Expanded Technology Access Program Responds to Interest from Leading Biopharmaceutical Companies and Lab Service Providers SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced commercial partnerships with five leading Contract Research Organizations (CROs) that expand access to NanoString’s Digital Spatial Profiling (DSP) technology. NanoString has entered […]
AMSBIO has introduced a new range of over 400 Isogenic cell lines that provide a reliable and efficient alternative to traditional human disease models. Isogenic cell lines can be used to model any disease with a genetic foundation. Cancer is one such disease for which isogenic human disease cell line models have been widely used. […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
